BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37886398)

  • 1. Be like water, my cells: cell plasticity and the art of transformation.
    Cammareri P; Myant KB
    Front Cell Dev Biol; 2023; 11():1272730. PubMed ID: 37886398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular Plasticity in Cancer.
    Yuan S; Norgard RJ; Stanger BZ
    Cancer Discov; 2019 Jul; 9(7):837-851. PubMed ID: 30992279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Epithelial-Mesenchymal Plasticity in Cancer Progression.
    Fontana R; Mestre-Farrera A; Yang J
    Annu Rev Pathol; 2024 Jan; 19():133-156. PubMed ID: 37758242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of Phenotypic Heterogeneity Associated with EMT and Stemness during Cancer Progression.
    Jolly MK; Celià-Terrassa T
    J Clin Med; 2019 Sep; 8(10):. PubMed ID: 31557977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial to mesenchymal transition during mammalian neural crest cell delamination.
    Zhao R; Trainor PA
    Semin Cell Dev Biol; 2023 Mar; 138():54-67. PubMed ID: 35277330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance.
    Gupta PB; Pastushenko I; Skibinski A; Blanpain C; Kuperwasser C
    Cell Stem Cell; 2019 Jan; 24(1):65-78. PubMed ID: 30554963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Plasticity in Mammary Gland Development and Breast Cancer.
    Wicker MN; Wagner KU
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states.
    Toneff MJ; Sreekumar A; Tinnirello A; Hollander PD; Habib S; Li S; Ellis MJ; Xin L; Mani SA; Rosen JM
    BMC Biol; 2016 Jun; 14():47. PubMed ID: 27317311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer cell plasticity during tumor progression, metastasis and response to therapy.
    Pérez-González A; Bévant K; Blanpain C
    Nat Cancer; 2023 Aug; 4(8):1063-1082. PubMed ID: 37537300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
    Jayachandran A; Dhungel B; Steel JC
    J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular mechanisms of plasticity in cancer.
    Torborg SR; Li Z; Chan JE; Tammela T
    Trends Cancer; 2022 Sep; 8(9):735-746. PubMed ID: 35618573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogram associated with epithelial-mesenchymal transition in tumor progression and metastasis.
    Wang Y; Dong C; Zhou BP
    Genes Dis; 2020 Jun; 7(2):172-184. PubMed ID: 32215287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer cell plasticity: Impact on tumor progression and therapy response.
    da Silva-Diz V; Lorenzo-Sanz L; Bernat-Peguera A; Lopez-Cerda M; Muñoz P
    Semin Cancer Biol; 2018 Dec; 53():48-58. PubMed ID: 30130663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic plasticity and epithelial-to-mesenchymal transition in the behaviour and therapeutic response of oral squamous cell carcinoma.
    Vig N; Mackenzie IC; Biddle A
    J Oral Pathol Med; 2015 Oct; 44(9):649-55. PubMed ID: 25594908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.
    Godde NJ; Galea RC; Elsum IA; Humbert PO
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):149-68. PubMed ID: 20461450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Epithelial Plasticity to Therapy Resistance.
    Santamaría PG; Moreno-Bueno G; Cano A
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31091749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMT Transition States during Tumor Progression and Metastasis.
    Pastushenko I; Blanpain C
    Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
    Ruscetti M; Dadashian EL; Guo W; Quach B; Mulholland DJ; Park JW; Tran LM; Kobayashi N; Bianchi-Frias D; Xing Y; Nelson PS; Wu H
    Oncogene; 2016 Jul; 35(29):3781-95. PubMed ID: 26640144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity.
    Vernot JP
    Front Mol Biosci; 2020; 7():63. PubMed ID: 32478091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding and targeting prostate cancer cell heterogeneity and plasticity.
    Tang DG
    Semin Cancer Biol; 2022 Jul; 82():68-93. PubMed ID: 34844845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.